Senti Biosciences Inc (SNTI)

Dec 04, 2025

Acute Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Domain | DelveInsight - GlobeNewswire Inc.

Dec 04, 2025

Dec 04, 2025

Senti Biosciences, Inc. to Host Conference Call and Webcast to Discuss SENTI-202 Clinical Data Being Presented At the American Society of Hematology Annual Meeting 2025 - marketscreener.com

Dec 04, 2025

Dec 04, 2025

Senti Biosciences, Inc. to Host Conference Call on Updated Clinical Results for SENTI-202 Prior to ASH Annual Meeting - Quiver Quantitative

Dec 04, 2025

Dec 04, 2025

Senti Bio (Nasdaq: SNTI) to host Dec. 9 webcast on updated SENTI-202 data from ASH 2025 - Stock Titan

Dec 04, 2025

Dec 04, 2025

How Senti Biosciences Inc. stock reacts to oil pricesJuly 2025 Price Swings & Capital Efficiency Focused Strategies - Newser

Dec 04, 2025

Nov 27, 2025

Senti Bio Reports Second Quarter 2025 Financial Results and Confirms Next Data Milestone for Phase 1 SENTI-202 Study in Acute Myeloid Leukemia (AML) Expected Q4 2025 - ADVFN

Nov 27, 2025

Nov 27, 2025

Form 8-KCurrent report - ADVFN

Nov 27, 2025

Nov 27, 2025

Check Out Senti Biosciences Inc (SNTI)’s Trade Data Rather Than the Analysts’ Views - Setenews

Nov 27, 2025

Nov 24, 2025

Senti Biosciences, Inc. (NASDAQ:SNTI) Receives $8.75 Consensus PT from Analysts - Defense World

Nov 24, 2025

Nov 23, 2025

Leerink Partners Initiates Coverage on Senti Biosciences (NASDAQ:SNTI) - Defense World

Nov 23, 2025

Nov 22, 2025

SNTI Stock Skyrockets on Initial Data From Phase I Cancer Study - MSN

Nov 22, 2025

Nov 22, 2025

Leerink Partners initiates coverage on Senti Biosciences stock with Outperform rating - Investing.com Australia

Nov 22, 2025

Nov 21, 2025

Leerink Partners Initiates Coverage of Senti Biosciences (SNTI) with Outperform Recommendation - Nasdaq

Nov 21, 2025

Nov 21, 2025

Leerink Partners initiates coverage on Senti Biosciences stock with Outperform rating By Investing.com - Investing.com South Africa

Nov 21, 2025

Nov 21, 2025

SNTI Stock Rating Update: Leerink Partners Initiates Coverage | - GuruFocus

Nov 21, 2025

Nov 20, 2025

Why Senti Biosciences Inc. stock is a must watch in 20252025 Breakouts & Breakdowns & Free Long-Term Investment Growth Plans - newser.com

Nov 20, 2025

Nov 20, 2025

Is Senti Biosciences Inc. stock vulnerable to regulatory risksJuly 2025 Closing Moves & Weekly High Return Forecasts - newser.com

Nov 20, 2025

Nov 19, 2025

Why Senti Biosciences Inc. stock could benefit from AI revolutionWeekly Gains Summary & Technical Entry and Exit Tips - newser.com

Nov 19, 2025

Nov 19, 2025

Is Senti Biosciences Inc. trending in predictive chart modelsQuarterly Market Summary & Expert Approved Momentum Ideas - newser.com

Nov 19, 2025

Nov 19, 2025

Combining machine learning predictions for Senti Biosciences Inc.Quarterly Profit Review & Weekly Breakout Stock Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

How Senti Biosciences Inc. stock benefits from global expansionEarnings Risk Summary & Growth Focused Stock Reports - newser.com

Nov 19, 2025

Nov 19, 2025

Building trade automation scripts for Senti Biosciences Inc.2025 Volume Leaders & Weekly Momentum Picks - newser.com

Nov 19, 2025

Nov 19, 2025

Will Senti Biosciences Inc. stock recover faster than peersEarnings Recap Report & Technical Analysis for Trade Confirmation - newser.com

Nov 19, 2025

Nov 19, 2025

Is Senti Biosciences Inc. forming a reversal patternJuly 2025 Pullbacks & Daily Market Momentum Tracking - newser.com

Nov 19, 2025

Nov 18, 2025

Will a bounce in Senti Biosciences Inc. offer an exitEarnings Risk Report & Risk Managed Investment Entry Signals - newser.com

Nov 18, 2025

Nov 18, 2025

Bicara Therapeutics (NASDAQ:BCAX) versus Senti Biosciences (NASDAQ:SNTI) Head to Head Analysis - Defense World

Nov 18, 2025